Please login to the form below

Not currently logged in
Email:
Password:

Ageing

This page shows the latest Ageing news and features for those working in and with pharma, biotech and healthcare.

In a U-turn, ICER takes more positive view of AbbVie’s Rinvoq

In a U-turn, ICER takes more positive view of AbbVie’s Rinvoq

At that time, ICER concluded that the incremental cost-effectiveness of Rinvoq versus AbbVie’s ageing blockbuster Humira (adalimumab) exceeded its $150, 000 (£119, 000) threshold.

Latest news

More from news
Approximately 7 fully matching, plus 208 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 80 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 29 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics